In late 1995, the FDA initiated important changes in the regulation of protein therapeutic drugs which eventually led to harmonization in the regulation of protein drugs and small molecule drugs. This change, often called the “WCBP initiative”, placed considerable emphasis on the analytical technologies used to characterize and analyze protein therapeutics. Several people meeting at the first “WCBP” Conference in January of 1997 saw a need for a professional development short course focused on training scientists in just these analytical technologies. The resulting course was first presented in March of 1998 and has since been presented to over 1500 scientists worldwide. While undergoing many changes and revisions over the years, the course, now titled the Analysis and Characterization of Protein Therapeutic Drugs, has remained true to the original mission of training scientists in the current, state-of-the-art, technologies used to meet the challenges inherent in analyzing and characterization of complex biomolecules.
Bioanalytical Technologies is dedicated to developing and presenting professional development courses on topics important to the biotechnology and analytical chemistry communities. These courses are carefully prepared by experts to meet the needs of scientists developing and refining their technical knowledge. The courses make use of colorful graphics to clearly present important concepts. Our principal instructor is an outstanding teacher with a facility for explaining the concepts and practices involved in a manner that makes them clear and easy to understand. Course attendees can anticipate educational, yet entertaining, presentations with ample opportunity for discussion and questions. These courses emphasize the practical and course attendees leave prepared to more effectively fulfill their technical assignments.
The class Fundamentals of Protein Chemistry has now been combined with The Analysis and Characterization of Protein Therapeutic Drugs into a three and a half day class. The first day focuses on proteins including fundamental structure of proteins and on protein modifications which may affect protein therapeutic drugs including glycosylation, deamidation and oxidation. The second day focuses on the role of chromatography in the analysis and characterization of protein therapeutic drugs, including reversed-phase, ion exchange, size exclusion and other forms of chromatography. The third day discusses capillary electrophoresis, theory and methods and how this technique is used in protein therapeutic drug analysis. Finally the technique of mass spectroscopy is thoroughly discussed on the afternoon of the third day and the morning of the fourth as it is applied to characterization and analysis of protein drugs.
April 10 – 13, 2018, in South San Francisco, California.
If you are interested in attending a class but are unable to attend this class, please email us at email@example.com. You will then be contacted as future classes are scheduled. The course is also available for presentation at company locations. On-site classes are practical for as few as five individuals.
Course Instructor: C. David Carr. A technical short course is only as good as its instructor. David has over forty-five years experience in the analytical technology field and is an expert in High Performance Liquid Chromatography. He is very familiar with capillary electrophoresis and mass spectrometry as applied to the analysis of polypeptides. Dave has provided instruction on HPLC and the use of HPLC in the analysis and characterization of polypeptides for many years. He has a facility for explaining the concepts and practices involved in the analysis of polypeptides in a manner that makes them clear and easy to understand. Course attendees can anticipate a very educational, yet entertaining, presentation with ample opportunity for discussion and questions.
Contact Bioanalytical Technologies at ...
By mail: P.O. Box 952 Wrightwood California 92397